Elevance Health, Inc. (NYSE:ELV) Shares Sold by Transform Wealth LLC

Transform Wealth LLC lessened its stake in shares of Elevance Health, Inc. (NYSE:ELV) by 3.1% during the fourth quarter, HoldingsChannel reports. The firm owned 5,934 shares of the company’s stock after selling 191 shares during the period. Transform Wealth LLC’s holdings in Elevance Health were worth $2,189,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of ELV. Raelipskie Partnership acquired a new stake in Elevance Health during the 3rd quarter valued at $26,000. PSI Advisors LLC purchased a new position in Elevance Health in the 3rd quarter valued at about $27,000. Eastern Bank acquired a new stake in shares of Elevance Health during the third quarter valued at about $31,000. Dunhill Financial LLC increased its position in shares of Elevance Health by 57.8% during the third quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock worth $37,000 after acquiring an additional 26 shares during the last quarter. Finally, Peterson Financial Group Inc. purchased a new stake in shares of Elevance Health during the third quarter worth about $44,000. Hedge funds and other institutional investors own 89.24% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Argus lowered Elevance Health from a “buy” rating to a “hold” rating in a research note on Friday, October 18th. Wells Fargo & Company decreased their price target on shares of Elevance Health from $593.00 to $495.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. StockNews.com upgraded shares of Elevance Health from a “hold” rating to a “buy” rating in a research note on Friday. Stephens reiterated an “underperform” rating on shares of Elevance Health in a research note on Friday, October 18th. Finally, Truist Financial dropped their target price on shares of Elevance Health from $520.00 to $480.00 and set a “buy” rating for the company in a research report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $536.53.

Elevance Health Stock Down 0.3 %

NYSE:ELV opened at $384.26 on Tuesday. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.56. The stock has a 50 day moving average of $387.20 and a 200-day moving average of $465.15. The firm has a market capitalization of $89.12 billion, a PE ratio of 14.01, a price-to-earnings-growth ratio of 1.09 and a beta of 0.84. Elevance Health, Inc. has a 52 week low of $362.21 and a 52 week high of $567.26.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.